Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-12-15
1989-10-31
Hollrah, Glennon H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514259, 544283, 544287, 544293, A61K 31505, C07D23984
Patent
active
048777900
ABSTRACT:
A quinazoline derivative represented by the following formula (I) ##STR1## or its pharmacologically acceptable acid addition salt and processes for production thereof. The quinazoline compound is used as a cerebral dysfunction remedying agent.
REFERENCES:
patent: 3609152 (1971-09-01), Hess et al.
patent: 3812127 (1974-05-01), Cronin et al.
patent: 4588725 (1986-05-01), Neumann
patent: 4672116 (1987-06-01), Bandurco et al.
Hara Hideaki
Hori Manabu
Iemura Ryuichi
Ito Keizo
Ohtaka Hiroshi
Hollrah Glennon H.
Kanebo Limited
LandOfFree
Quinazoline derivative, processes for its production, and cerebr does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Quinazoline derivative, processes for its production, and cerebr, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Quinazoline derivative, processes for its production, and cerebr will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-626240